Lasa Supergenerics Ltd

NSE: LASA · BSE: 540702 · Pharmaceuticals & Biotechnology · 15 announcements

Share price: ₹5.32
Market cap: ₹26.65 Cr
Revenue (annual): ₹25.14 Cr
Net profit (annual): ₹-34.09 Cr
P/E (TTM): -1.6×Sector 47.3×
Promoter holding: 53.65%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 5 Other Announcement 3 Board Meeting Date 2 Management Change 1 Debt & Borrowing 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

4 Aug 2026 12:32 IST BSE

Board Meeting Date

Lasa Supergenerics Board Meeting Date

Lasa Supergenerics has scheduled a board meeting for August 14, 2026. The board will consider the unaudited financial results for the quarter ended June 30, 2026.

Read the filing ↗

19 May 2026 13:32 IST BSE

Board Meeting Date

Lasa Supergenerics Board Meeting Date

Lasa Supergenerics scheduled a board meeting for May 29, 2026, to approve audited financial results. Trading window remains closed until 48 hours post-declaration.

Read the filing ↗